Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Venclyxto 100 mg film-coated tablets

Active Ingredient:
venetoclax
Company:  
AbbVie Ltd See contact details
ATC code: 
L01XX52
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Venclyxto Patient Alert Card

{healthcare_pro_orange} For Healthcare Professionals

Venclyxto Patient Card with safety information about Venclyxto for patients with Chronic Lymphocytic Leukaemia (CLL). This card contains information for the patient with regards to Tumour Lysis Syndrome and Venclyxto.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

AbbVie Ltd
Company image
Address
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
WWW
www.abbviemedinfo.com
WWW
www.abbvie.co.uk
Telephone
+44 (0)1628 561 092
Medical Information e-mail
[email protected]
Out of Hours Telephone
+44 (0)1628 561 092